Hepatic Neoplasia

Latest Articles

Leisure-Time Physical Activity Linked to Lower Cancer Risk

Leisure-time physical activity at recommended levels is associated with a significantly lower risk for seven cancer types.

Lipophilic Statins Decrease Hepatocellular Carcinoma and Death in Chronic Hepatitis

By

Virginia A. Schad, PharmD, RPh

From a nationwide Swedish registry, researchers found data that showed in patients with hepatitis B or C virus infection, the long-term hepatocellular carcinoma risk was lower in patients who were treated with lipophilic statins.

First Duodenoscope With Disposable Elevator Piece Cleared by FDA

By

Dibash Kumar Das, PhD

The FDA has cleared the first duodenoscope with a disposable sterile elevator piece, a first in the United States. The design will reduce the number of parts that need to be cleaned and disinfected (reprocessed) between uses.

Investigational Farnesoid X Receptor Agonist Gets Fast Track Status for NASH

By

Brian Park, PharmD

The FDA has granted Fast Track designation to TERN-101 (Terns Pharmaceuticals) for the treatment of non-alcoholic steatohepatitis.

Natural History and Tumor Development: Adeno-Associated Virus in the Liver

By

Gastroenterology Advisor Contributing Writer

Study provides a portrait of wild-type AAV infection in the liver with an identification of molecular forms, viral genotypes, viral integrations, and helper virus relationship and with AAV insertions positive selected during HCC development on noncirrhotic liver, which challenges the concept of AAV as nonpathogenic.

When to Use Direct-Acting Antivirals in Hepatocellular Carcinoma

By

Christin Melton

Researchers found data that showed treatment with direct-acting antivirals in patients with hepatocellular carcinoma with advanced cirrhosis improves liver function and could be categorized as safe.

Statins Linked to Lower Risk of Liver Cancer in Patients With HCV, HBV

By

Christina Bennett, MS

Lipophilic statins were linked to a lower risk of hepatocellular carcinoma and death in a cohort of patients with chronic hepatitis B/C.

Initial Staging Images for Melanoma Often Show Incidental Findings

By

Gastroenterology Advisor Contributing Writer

The study results provide additional context for clinical interpretation of radiographic evaluations of patients with melanoma and help inform the risk-benefit analysis of staging recommendations.

Phase 3 Trial for Oncolytic Viral Therapy Pexa-Vec Terminated Early

By

Victoria Forster, PhD

Pexa-Vec, in combination with sorafenib, has failed an interim futility analysis, leading to the early termination of the trial.

Aspirin May Improve Liver Function After Embolization of HCC

Aspirin therapy can improve liver function and survival in patients who have received chemoembolization or transarterial embolization for hepatocellular carcinoma.

Physical Activity and Hepatobiliary Cancers: Is There a Connection?

By

Madeline Morr

Physical activity was found to be associated with a reduced risk for hepatocellular carcinoma.